Cavalier Investments’s Genmab GMAB Stock Holding History

Cavalier Investments’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,100	Closed	-$320K	–	93
2020 Q1	$320K	Hold	15,100	–	–	0.19%	81
2019 Q4	$337K	Buy	+15,100	New	+$330K	0.15%	109

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Cavalier Investments's GMAB Position: Q2 2020 in Review

Cavalier Investments sold out of Genmab (GMAB) in Q2 2020, closing a stake of 15,100 shares — an estimated $320K sold.

Cavalier Investments first reported a position in GMAB in Q4 2019 and held it in 2 quarters. The position peaked at $337K in Q4 2019. 174 funds tracked by Wall St. Rank hold GMAB as of Q2 2020.

Cavalier Investments reported no remaining Genmab position as of Q2 2020 after selling out during the quarter.
Cavalier Investments sold 15,100 Genmab shares in Q2 2020, an estimated $320K.
Cavalier Investments first reported a position in Genmab in Q4 2019 and held it in 2 quarters.
Cavalier Investments's Genmab position peaked at $337K in Q4 2019.
174 funds tracked by Wall St. Rank held Genmab as of Q2 2020.

Based on Cavalier Investments's 13F filing for Q2 2020, filed 10 Aug 2020.